This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cruchaga, C. et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 505, 550–554 (2014)
Heilmann, S. et al. PLD3 in non-familial Alzheimer's disease. Nature 520,http://dx.doi.org/10.1038/nature14039 (2015)
Lambert, J.-C. et al. PLD3 and sporadic Alzheimer's disease risk. Nature 520,http://dx.doi.org/10.1038/nature14036 (2015)
van der Lee, S. J. et al. PLD3 variants in population studies. Nature 520,http://dx.doi.org/10.1038/nature14038 (2015)
Lambert, J. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genet. 45, 1452–1458 (2013)
Blacker, D. et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 12, 23–32 (2003)
De, G., Yip, W. K., Ionita-Laza, I. & Laird, N. Rare variant analysis for family-based design. PLoS ONE 8, e48495 (2013)
Cantarel, B. L. et al. BAYSIC: a Bayesian method for combining sets of genome variants with improved specificity and sensitivity. BMC Bioinform. 15, 104 (2014)
Laird, N. M., Horvath, S. & Xu, X. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 19 (suppl. 1). S36–S42 (2000)
Won, S. et al. On the analysis of genome-wide association studies in family-based designs: a universal, robust analysis approach and an application to four genome-wide association studies. PLoS Genet. 5, e1000741 (2009)
Lill, C. M. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 8, e1002548 (2012)
Author information
Authors and Affiliations
Contributions
R.E.T., L.B., B.V.H. and C.M.L. designed the study; B.V.H. and K.M. generated data; C.M.L., D.Q. and C.L. performed statistical analyses; B.V.H., L.B., C.M.L. and R.E.T. wrote the paper.
Corresponding authors
Ethics declarations
Competing interests
Declared none.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Hooli, B., Lill, C., Mullin, K. et al. PLD3 gene variants and Alzheimer's disease. Nature 520, E7–E8 (2015). https://doi.org/10.1038/nature14040
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14040
This article is cited by
-
Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
Molecular Neurodegeneration (2022)
-
Swollen axons impair neuronal circuits in Alzheimer’s disease
Nature (2022)
-
Structural insights into PA3488-mediated inactivation of Pseudomonas aeruginosa PldA
Nature Communications (2022)
-
PLD3 affects axonal spheroids and network defects in Alzheimer’s disease
Nature (2022)
-
Benefits and Challenges of Rare Genetic Variation in Alzheimer’s Disease
Current Genetic Medicine Reports (2019)